Skip to main content

Open Surgery

0
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Medical Microinstruments
3 programs
Symani Surgical SystemN/A1 trial
Symani Surgical SystemN/A1 trial
Symani Surgical SystemN/A1 trial
Active Trials
NCT06628219Not Yet Recruiting1,000Est. Feb 2030
NCT04843436Completed427Est. Jul 2025
NCT06725030Recruiting455Est. Dec 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Medical MicroinstrumentsSymani Surgical System
Medical MicroinstrumentsSymani Surgical System
Medical MicroinstrumentsSymani Surgical System

Clinical Trials (3)

Total enrollment: 1,882 patients across 3 trials

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

Start: Sep 2025Est. completion: Dec 2027455 patients
N/ARecruiting

A Global, Prospective, Real-World, Investigation of the Symani® Surgical System for Microsurgical Anastomosis

Start: Feb 2025Est. completion: Feb 20301,000 patients
N/ANot Yet Recruiting

PRIMO Post-Market Clinical Follow Up Study

Start: Apr 2021Est. completion: Jul 2025427 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 1,882 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.